Dr. Thompson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
250 25th Ave N
Ste 100
Nashville, TN 37203Phone+1 615-320-5090Fax+1 615-320-1225
Education & Training
- Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 1991 - 1993
- Wake Forest University Baptist Medical CenterResidency, Internal Medicine, 1988 - 1991
- University of Tennessee Health Science Center College of MedicineClass of 1988
Certifications & Licensure
- TN State Medical License 1991 - 2026
- NC State Medical License 1989 - 1992
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 12 citationsClinical Activity and Safety of Atezolizumab in a Phase 1 Study of Patients With Relapsed/Refractory Small-Cell Lung CancerAnne C. Chiang, Lecia V. Sequist, Jill Gilbert, Paul Conkling, D. S. Thompson
Clinical Lung Cancer. 2020-05-12 - 10 citationsRandomized phase 2 trial of pemetrexed, pemetrexed/bevacizumab, and pemetrexed/carboplatin/bevacizumab in patients with stage IIIB/IV non–small cell lung cancer and an...David R. Spigel, John D. Hainsworth, Mathew John Joseph, Dianna Shipley, M. Kelly Hagan
Cancer. 2018-05-01 - 8 citationsBendamustine, bortezomib and rituximab produces durable complete remissions in patients with previously untreated, low grade lymphoma.Ian W. Flinn, D. S. Thompson, Ralph V. Boccia, Gerald Miletello, Andrew Lipman
British Journal of Haematology. 2018-02-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: